Petroleo Brasileiro SA Petrobras
PBR
Adobe
ADBE
Ecopetrol
EC
Toll Brothers
TOL
Meta Platforms
META
US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 18.370
- -0.650-3.42%
Trading Mar 25 13:14 ET
1.11BMarket Cap-5.78P/E (TTM)
19.500High18.210Low116.50KVolume19.000Open19.020Pre Close2.15MTurnover0.25%Turnover RatioLossP/E (Static)60.28MShares40.83552wk High3.06P/B856.42MFloat Cap17.24052wk Low--Dividend TTM46.62MShs Float318.750Historical High--Div YieldTTM6.78%Amplitude2.650Historical Low18.495Avg Price1Lot Size
Spyre Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | -61.96%886K | 0 | 0 | 10.08%688K | -85.46%198K |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | -61.96%886K | --0 | --0 | 10.08%688K | -85.46%198K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 61.12%208.57M | 28.27%61.25M | 66.62%55.39M | 49.92%44.15M | 151.39%47.77M | 48.61%129.45M | 147.05%47.75M | 75.62%33.24M | 27.77%29.45M | -26.35%19M |
| Selling and administrative expenses | 14.59%45.78M | -23.46%10.77M | 24.04%10.65M | -4.57%11.51M | 145.72%12.85M | 40.01%39.95M | 177.06%14.07M | 23.48%8.58M | 57.16%12.06M | -40.76%5.23M |
| -General and administrative expense | 14.59%45.78M | -23.46%10.77M | 24.04%10.65M | -4.57%11.51M | 145.72%12.85M | 40.01%39.95M | 177.06%14.07M | 23.48%8.58M | 57.16%12.06M | -40.76%5.23M |
| Research and development costs | 81.88%162.79M | 49.88%50.48M | 81.44%44.74M | 87.71%32.64M | 153.54%34.93M | 52.79%89.5M | 136.35%33.68M | 105.89%24.66M | 13.09%17.39M | -18.86%13.78M |
| Operating profit | -62.23%-208.57M | -28.27%-61.25M | -66.62%-55.39M | -53.50%-44.15M | -154.04%-47.77M | -51.64%-128.56M | -149.21%-47.75M | -77.25%-33.24M | -28.26%-28.76M | 23.06%-18.81M |
| Net non-operating interest income expense | 246.71%21.31M | 39.99%5.78M | 314.39%5.18M | 1,591.43%5.92M | 955.24%4.43M | 634.41%6.15M | 906.34%4.13M | 334.38%1.25M | 236.54%350K | 1,100.00%420K |
| Non-operating interest income | 246.71%21.31M | 39.99%5.78M | 314.39%5.18M | 1,591.43%5.92M | 955.24%4.43M | 634.41%6.15M | 906.34%4.13M | 334.38%1.25M | 236.54%350K | 1,100.00%420K |
| Other net income (expense) | 90.43%-20.71M | 95.82%-818K | -131.81%-18.8M | 99.68%-610K | -570.83%-483K | -3,091,314.29%-216.4M | -61,000.00%-19.55M | -33,895.83%-8.11M | -3,773,380.00%-188.66M | -140.00%-72K |
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---83.53M | --0 | ---25.36M | ---58.17M | ---- |
| Special income (charges) | --0 | --0 | --0 | --0 | ---- | ---113.74M | --1.84M | --14.91M | ---130.49M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --130.19M | --0 | ---298K | --130.49M | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | --0 | ---- | ---- | --16.45M | --1.84M | --14.61M | ---- | ---- |
| Other non- operating income (expenses) | -8.27%-20.71M | 96.18%-818K | -902.82%-18.8M | -7,525.00%-610K | -570.83%-483K | -273,185.71%-19.13M | -66,750.00%-21.39M | 9,658.33%2.34M | -260.00%-8K | -140.00%-72K |
| Income before tax | 38.62%-207.97M | 10.90%-56.3M | -72.08%-69.01M | 82.11%-38.84M | -137.43%-43.83M | -303.59%-338.82M | -236.35%-63.18M | -117.45%-40.1M | -872.82%-217.07M | 24.46%-18.46M |
| Income tax | 296.15%51K | 1K | 500.00%18K | 0 | 188.89%32K | 80.88%-26K | 0 | 101.44%3K | -22.22%7K | -36K |
| Net income | 38.60%-208.02M | 10.90%-56.3M | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -304.21%-338.79M | -235.67%-63.18M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M |
| Net income continuous Operations | 38.60%-208.02M | 10.90%-56.3M | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -304.21%-338.79M | -235.67%-63.18M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 38.60%-208.02M | 10.90%-56.3M | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -304.21%-338.79M | -235.67%-63.18M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M |
| Preferred stock dividends | -76.03%58.46M | 243.91M | ||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -57.62%-149.56M | -98.80%2.17M | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -13.21%-94.88M | 1,060.19%180.73M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M |
| Basic earnings per share | 76.89%-3.18 | -116.16%-0.81 | -23.26%-1.06 | 98.53%-0.59 | 85.28%-0.72 | 44.65%-13.76 | 206.87%5.0122 | 82.23%-0.86 | -494.67%-40.14 | 47.14%-4.89 |
| Diluted earnings per share | 76.89%-3.18 | -116.16%-0.81 | -23.26%-1.06 | 98.53%-0.59 | 85.28%-0.72 | 44.65%-13.76 | 206.87%5.0122 | 82.23%-0.86 | -494.67%-40.14 | 47.14%-4.89 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.